Plague still infects people every year, yet you can’t walk into a clinic in the US or Europe and get a shot against it.1PubMed Central. Plague vaccine: recent progress and prospects The vaccines once given were dropped or never approved, and the modern replacements are still being tested. The protection that works today comes from ordinary antibiotics, which cut bubonic plague deaths from about two-thirds to roughly one in eight.2PubMed Central. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response For a traveler or a hiker in the American West, the real safeguard is avoiding fleas and getting treated fast.
Where You Can and Can’t Get a Plague Vaccine
The US Food and Drug Administration has never approved a plague vaccine.3PubMed Central. Combination of live-attenuated and adenovirus-based vaccines provides immediate and durable protection against Yersinia pestis in mice Most of the world is in the same position, with no plague vaccine holding a full license.4PubMed Central. Plague vaccine: recent progress and prospects The exception is a weakened live vaccine called EV76, which is still approved in China and Russia.5PubMed Central. Progress on the research and development of plague vaccines with a call to action Versions of it have been used in Mongolia and several Eastern European countries.6PubMed Central. Biodefense Research Two Decades Later: Worth the Investment? So an ordinary traveler cannot get vaccinated before a trip, even to a plague area.
Plague isn’t on the standard travel vaccine lists the way yellow fever or typhoid are. A travel clinic will likely talk about avoiding fleas and rodents, and may mention that antibiotics can be prescribed after a known exposure.
The Chinese and Russian vaccine isn’t a workaround. It is approved only under those countries’ own regulators, and it isn’t sold or offered to foreign visitors as a travel shot. Approval there means that country judged the vaccine acceptable for its own people, not that it passed the review standards of the FDA or European authorities.
The useful trip-planning question is whether your route includes rural areas with known plague activity, since risk follows rodents and fleas rather than big cities or ordinary tourist stops. If it does, pack insect repellent, learn the early symptoms, and know you can seek care quickly if they appear.
Why the Old Plague Vaccines Were Dropped
Waldemar Haffkine made one of the first plague vaccines in India during the plague that hit Bombay in 1896.7PubMed. Waldemar Mordecai Haffkine, CIE (1860-1930): prophylactic vaccination against cholera and bubonic plague in British India It was given to large numbers of people in mass inoculation campaigns.8PubMed. Waldemar Mordecai Haffkine, CIE (1860-1930): prophylactic vaccination against cholera and bubonic plague in British India But in 1902, 19 people in a Punjab village died of tetanus from a contaminated batch.9PubMed. Waldemar Mordecai Haffkine, CIE (1860-1930): prophylactic vaccination against cholera and bubonic plague in British India In the early 1900s, vaccine was made in bulk and filled into bottles by hand, so one contamination could reach everyone who got doses from the same batch. The deaths were a manufacturing failure, not a flaw in the idea of vaccinating against plague.
The US once made a killed whole-cell plague vaccine for soldiers and lab workers. Older CDC guidance recommended it only for high-risk workers, not travelers. It needed repeated doses and boosters, often caused sore arms and fever, and was eventually discontinued. It is no longer made in the US.
A live attenuated vaccine uses a weakened version of the plague germ to train the body.10Research. Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries The EV76 strain was used this way in many countries.11Research. Genetic variations of live attenuated plague vaccine strains (Yersinia pestis EV76 lineage) during laboratory passages in different countries A killed vaccine, by contrast, uses dead germs that can’t multiply. Weakened live germs still multiply a little, which often produces a stronger immune response from fewer doses. That same multiplying is why these vaccines cause strong reactions such as fever, soreness and swelling, making them unsuitable for wide human use,12PubMed Central. A novel sORF gene mutant strain of Yersinia pestis vaccine EV76 offers enhanced safety and improved protection against plague and why they call for extra caution in people with weakened immune systems.
Side effects weigh heavily because vaccines go to healthy people, and antibiotics already treat plague well. Concern over these live vaccines pushed researchers toward newer designs.13PubMed Central. Biodefense Research Two Decades Later: Worth the Investment?
How Plague Is Treated and Prevented Without a Vaccine
Without treatment, about 66% of people with bubonic plague die.14PubMed Central. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response With antibiotics, that falls to about 13%.15PubMed Central. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response In recorded cases, death rates were about 10% with tetracyclines, 12% with fluoroquinolones such as ciprofloxacin, and 13% with drugs like streptomycin or gentamicin.16PubMed. Antimicrobial Treatment of Human Plague: A Systematic Review of the Literature on Individual Cases, 1937-2019
Speed matters more than the specific drug. Untreated bubonic plague can spread to the blood or lungs, and those forms are far more deadly and progress within days.
Doctors can also give antibiotics to people exposed to plague, such as close contacts of someone with the lung form, before symptoms appear.17PubMed Central. Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response Pneumonic plague, the lung form, spreads from person to person through coughing. So if you’ve been near a plague patient or handled a sick animal in a plague area, tell a doctor right away.
Symptoms that should send you to a doctor fast are sudden fever, chills, headache and weakness, often with a swollen, very painful lymph node, typically in the groin, armpit or neck. They usually start 2 to 8 days after a flea bite. Mention any time around rodents, fleas or sick pets in a plague area so the doctor tests for it.
Plague is diagnosed by testing a sample such as blood or fluid from a swollen lymph node, but doctors who suspect it in someone with a plausible exposure usually start antibiotics without waiting for results. Serious illness is typically treated in a hospital, often with antibiotics through a vein, while milder cases may be treated with pills. Treatment generally runs about ten days or until well after the fever has gone, so finish the course even when you feel better.
In plague areas, use insect repellent and keep pets on flea control. Don’t touch sick or dead rodents, squirrels or rabbits, and keep rodent food and nesting spots away from your home.
The New Plague Vaccines in Testing
Two proteins on the plague germ, called F1 and V, are what the immune system most needs to recognize for protection in animals.18PubMed Central. Plague Vaccine Development: Current Research and Future Trends So researchers built vaccines from just these proteins rather than the whole germ.19PubMed. Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine Using selected proteins means no living or whole germ is injected, which removes the risk of the vaccine causing plague-like illness. The proteins are made in the lab rather than grown from cultured plague germs, which is simpler and safer for factory workers.
In an early human trial, every volunteer made antibodies after two doses.20PubMed Central. Human immune response to a plague vaccine comprising recombinant F1 and V antigens Protein vaccines tend to need a booster to build strong antibodies, which is why the trials used multiple doses. A later trial found side effects were mostly mild to moderate, mainly arm pain, with no serious ones.21PubMed Central. Immunogenicity and safety of subunit plague vaccine: A randomized phase 2a clinical trial In 2017 the FDA gave one F1-V vaccine a special status for rare-disease products after three human trials.22PubMed Central. Biodefense Research Two Decades Later: Worth the Investment? That status brings benefits such as development support and regulatory advice, which helps the maker continue. It is not approval to sell the vaccine, and it doesn’t mean regulators have judged it safe and effective enough, a decision that still needs further evidence.
Newer platforms are further back. An mRNA vaccine using F1, similar in design to COVID-19 shots, protected mice from plague with a single dose.23PubMed Central. A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium A two-protein RNA vaccine protected about 70 to 80% of mice against bubonic plague.24PubMed Central. Novel Bivalent mRNA‐LNP Vaccine for Highly Effective Protection against Pneumonic Plague Nasal vaccines fully protected mice against the lung form in some tests.25PubMed Central. Intranasal delivery of a protein subunit vaccine using a Tobacco Mosaic Virus platform protects against pneumonic plague A spray appeals for that form because it starts in the airways.
But mouse results often don’t carry over to people. Only the F1-V protein vaccines have reached human trials, and those measured safety and antibodies, not whether people avoided plague. The mRNA and nasal vaccines are still in animals, and no date for public availability has been announced.
Why Plague Vaccines Are So Hard to Approve
Plague is too rare to show that a vaccine prevents it in a normal trial, and infecting volunteers would be unethical.26PubMed. Humoral and cellular immune correlates of protection against bubonic plague by a live Yersinia pseudotuberculosis vaccine A usual trial counts who gets sick in vaccine and placebo groups, which needs many cases. With so few plague cases in any one place, a trial would need enormous numbers of volunteers and years of waiting.
So the FDA can approve such products using solid animal studies.27PubMed Central. Prevention of pneumonic plague in mice, rats, guinea pigs and non-human primates with clinical grade rV10, rV10-2 or F1-V vaccines Researchers show that vaccinated animals survive a dose of plague that kills unvaccinated ones, ideally in more than one species. They must also find a blood marker, such as antibody levels, that predicts protection in people.28PubMed Central. The Role of Immune Correlates and Surrogate Markers in the Development of Vaccines and Immunotherapies for Plague
The germ adds to the difficulty. It injects proteins into immune cells to disable them and delays the body’s early alarm signals that call in white blood cells. A vaccine must prepare defenses fast enough to beat that head start.
Money is a factor too. Few ordinary buyers exist for a vaccine against a rare disease, and US defense programs funded the F1-V trials because of bioterrorism concerns. That keeps work going but ties progress to defense priorities.
Where Plague Still Infects People
In the US, most cases come from northern New Mexico, northern Arizona and southern Colorado, and from California, southern Oregon and far western Nevada.29Centers for Disease Control and Prevention. Plague Maps and Statistics Almost all recent US cases were in small towns, villages and farm areas, not cities.30Centers for Disease Control and Prevention. Plague Maps and Statistics A typical city dweller visiting a national park faces a low risk, which rises with behaviors such as handling a dead animal or sleeping near burrows.
Prairie dogs, ground squirrels and their fleas carry the germ in the West. Pet cats can catch it from rodents and pass it to owners. An oral bait vaccine is being used on prairie dogs to protect them and endangered black-footed ferrets, and it may also reduce plague in the animals that spread it to people.
Worldwide, since the 1990s most human cases have been in Africa, especially the Democratic Republic of the Congo and Madagascar.31World Health Organization. Plague Plague circulates in animals on every continent except Oceania.32World Health Organization. Plague In Latin America, cases persist in a handful of mostly poor, high-altitude areas.33PubMed Central. Where Does Human Plague Still Persist in Latin America?
Plague survives in wild rodent populations and their fleas, passing among them in a cycle people can’t easily remove. Human cases occur when an infected flea bites a person or someone handles an infected animal. Because the cycle is in wildlife, areas can stay quiet for years and then show cases again when animal numbers or conditions shift.
Who Gets Vaccinated Today and Why Drug Resistance Matters
Vaccination is meant for people whose exposure can’t be avoided:
- Lab and field workers handling antibiotic-resistant plague strains.34Centers for Disease Control and Prevention. Plague Vaccine
- People doing airborne plague experiments.35Centers for Disease Control and Prevention. Plague Vaccine
- Field workers in plague areas, such as some disaster zones, where exposure can’t be avoided.36Centers for Disease Control and Prevention. Plague Vaccine
- Volunteers and advisers living in rural plague areas where avoiding rodents and fleas is impossible.37Centers for Disease Control and Prevention. Plague Vaccine
For these groups, avoidance and after-the-fact antibiotics may be too uncertain, so a vaccine adds a layer. For ordinary travelers and hikers, avoidance and quick treatment already work well.
Resistance is part of why. A streptomycin-resistant strain spread during a lung-plague outbreak in Madagascar,38Clinical Infectious Diseases. Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak and the same resistance change has arisen on its own at least three times.39Clinical Infectious Diseases. Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak One Madagascar strain resisted eight antibiotics, including those used to treat and prevent plague.40PubMed Central. Understanding the Persistence of Plague Foci in Madagascar Resistant strains are a main reason experts still want a vaccine.
If the germ resists the drug a doctor picks first, treatment can be delayed until a working drug is found, and delay is what raises the death rate. Resistance to drugs used for preventive treatment after exposure would also weaken the main protection people rely on now. A vaccine wouldn’t depend on which antibiotics the germ resists. For you today, resistant strains remain rare, and lab testing helps doctors choose a drug that works.